Apogee Therapeutics Inc. (APGE)
(Real Time Quote from BATS)
$46.45 USD
-1.42 (-2.97%)
Updated May 23, 2024 02:03 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/26/24 |
---|---|
Current Quarter | -0.64 |
EPS Last Quarter | -0.64 |
Last EPS Surprise | -6.67% |
ABR | 1.00 |
Earnings ESP
|
2.98% |
---|---|
Current Year | -2.64 |
Next Year | -2.96 |
EPS (TTM) | -5.25 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.64 | -0.67 | -2.64 | -2.96 |
# of Estimates | 4 | 3 | 5 | 5 |
Most Recent Consensus | -0.59 | -0.60 | -2.43 | -2.59 |
High Estimate | -0.58 | -0.60 | -2.20 | -2.59 |
Low Estimate | -0.70 | -0.80 | -3.15 | -3.35 |
Year ago EPS | -3.78 | -0.51 | -3.36 | -2.64 |
Year over Year Growth Est. | 83.07% | -31.37% | 21.43% | -12.12% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 2 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 0 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.64 | -0.67 | -2.64 | -2.96 |
7 Days Ago | -0.64 | -0.67 | -2.64 | -2.96 |
30 Days Ago | -0.66 | -0.71 | -2.67 | -3.06 |
60 Days Ago | -0.66 | -0.71 | -2.49 | -2.81 |
90 Days Ago | -0.51 | -0.57 | -2.09 | -2.35 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.62 | -0.60 | -2.75 | -2.92 |
Zacks Consensus Estimate | -0.64 | -0.67 | -2.64 | -2.96 |
Earnings ESP | 2.98% | 10.00% | -4.15% | 1.20% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.64 | -0.32 | -0.51 | -3.78 | NA |
Estimate | -0.60 | -0.45 | -0.38 | -0.47 | NA |
Difference | -0.04 | 0.13 | -0.13 | -3.31 | -0.84 |
Surprise | -6.67% | 28.89% | -34.21% | -704.26% | -179.06% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more